Cyclopharm’s 2026 Stock Pulse: Radiopharma Growth & Lung Imaging Outlook
Explore Cyclopharm Ltd’s radiopharmaceutical strategy—focus on lung & cancer imaging, current market stats, and future growth prospects.
3 minutes to read
Cyclopharm Ltd
Cyclopharm Raises A$14 M to Fuel U.S. Expansion with New Share Purchase Plan
Cyclopharm raises A$14 million and launches a share purchase plan to boost US expansion of its Technegas® radiopharmaceutical, driving growth and investor confidence.
2 minutes to read
Cyclopharm Ltd Faces Market Challenges Amidst Advances in Radiopharmaceuticals
Cyclopharm Ltd, a Melbourne-based company, has established itself as a key player in the radiopharmaceutical industry, providing crucial products for lung and cancer tumor imaging, despite experiencing fluctuations in its share price.
2 minutes to read